Gliomas Unknown Status Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Glioma / [M]Glioma NOS

IndicationStatusPhase
DBCOND0032593 (Gliomas)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00660621A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade GliomaTreatment